An improved automated immunoassay for C-reactive protein on the Dimension1 clinical chemistry system
2000

Improved Automated Immunoassay for C-Reactive Protein

Sample size: 622 publication Evidence: high

Author Information

Author(s): Tie Q. Wei, Steve Kramer, Victor P. Chu, Dave Hudson, Daniel Kilgore, Sue Salyer, Grace Parker, Amy Eyberger, Rene Arentzen, Heikki Koiv

Primary Institution: Dade Behring

Hypothesis

The goal was to develop a highly sensitive CRP assay with an extended range on the Dimension1 clinical chemistry system.

Conclusion

The improved CRP method provides a sensitive, accurate, and rapid approach to quantify CRP in serum and plasma.

Supporting Evidence

  • The improved CRP method was linear to 265.1 mg/l with a detection limit between 0.2 and 0.5 mg/l.
  • The method detects antigen excess from the upper assay limit to 2000 mg/l.
  • Calibration was stable for 60 days.
  • The within-run reproducibility was less than 5.1% and total reproducibility ranged from 1.1 to 6.7%.
  • Minimal interference was observed from sera of patients with elevated IgM, IgG, and IgA.

Takeaway

This study created a better test for measuring a protein that shows inflammation in the body, making it easier for doctors to get accurate results.

Methodology

The study involved optimizing a particle-enhanced turbidimetric immunoassay and comparing it with existing methods using disease state specimens.

Potential Biases

Potential bias from the use of multiple instruments and reagent lots.

Limitations

The study did not test all reagent lots manufactured for the antigen excess detection.

Participant Demographics

Specimens were from several hospitals, including patients with various conditions.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% confidence interval: 0.975 to 0.993

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication